EHA / 14th Congress / Program overview per day / Friday Program

Lunch Debate

Education Session Lunch Debates EHA / ESH Joint Symposium Meet-the-Expert Opening Ceremony Molecular Hematopoiesis Workshop Poster Session

LUNCH DEBATE

11:30 – 12:30, Hall 3

SHOULD WE ATTEMPT TO DISCONTINUE IMATINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA?

Chair: J Goldman (Imperial College London, London, United Kingdom)

  • YES:

    F Mahon (Université Victor Segalen Bordeaux, Bordeaux, France)

  • NO:

    S O’Brien (Northern Institute for Cancer Research, Newcastle, United Kingdom)

LUNCH DEBATE

11:30 – 12:30, Hall 2.1

ARE MINIMAL RESIDUAL DISEASE STUDIES IMPORTANT FOR DISEASE MANAGEMENT IN ACUTE MYELOID LEUKEMIA

Chair: F Lo Coco (University Tor Vergata, Rome, Italy)

  • YES:

    D Grimwade (King's College London School of Medicine, London, United Kingdom)

  • NO:

    C Schiffer (Karmanos Cancer Institute, Detroit, USA)

 

[Print view ]